Who published this market news?

TradingView published this market news item.

Avanos receives regulatory approvals, merger expected to close by July 27 pending shareholder vote

Avanos received all required regulatory approvals for its pending acquisition by affiliates of funds advised by American Industrial Partners and expects to close the transaction by July 27, 2026.Key Highlights:Original SEC Filing: AVANOS MEDICAL, INC. [ AVNS ] - 8-K - Jul. 02, 2026This is an AI-pow…

Avanos received all required regulatory approvals for its pending acquisition by affiliates of funds advised by American Industrial Partners and expects to close the transaction by July 27, 2026.

Key Highlights:

All required regulatory approvals obtained for the proposed merger with AIP-affiliated funds.
Transaction expected to close no later than July 27, 2026, subject to stockholder approval and customary conditions.
Avanos special stockholder meeting to vote on the merger set for July 22, 2026 at 9:00 a.m. ET in Atlanta.
Company and AIP emphasize partnership aims to support Avanos’ next phase of growth, innovation and commercial execution.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.